HAT therapy for sepsis: A review of the therapeutic rationale and current clinical evaluation status.

Sun, Yali; Yang, Yongfang; Ye, Zhuoyi; Sun, Tongwen

Sun, Yali; Yang, Yongfang; Ye, Zhuoyi; Sun, Tongwen.

Afiliación

Sun Y; Department of General ICU, The First Affiliated Hospital of Zhengzhou University, Henan Key Laboratory of Critical Care Medicine, Zhengzhou Key Laboratory of Sepsis, Zhengzhou 450052, Henan, China.
Yang Y; Henan Engineering Research Center for Critical Care Medicine, Department of General ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
Ye Z; Henan Engineering Research Center for Critical Care Medicine, Department of General ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
Sun T; Henan Engineering Research Center for Critical Care Medicine, Department of General ICU, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.

J Intensive Med ; 3(4): 320-325, 2023 Oct 31.

Article en En | MEDLINE | ID: mdl-38028642

Palabras clave

HAT therapy; Hydrocortisone; Metabolic resuscitation; Sepsis; Thiamine; Vitamin C

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Intensive Med Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google